Press Release Aug 13 2021
Filed with NSE · · 3 pages · English
Summary by 6ix AI
The collaboration aims to facilitate the large-scale manufacturing and supply of these vaccines in India. Dr. Habil Khorakiwala, the Founder Chairman of Wockhardt Group, expressed pride in contributing to the global fight against the pandemic through this partnership. The press release highlights the efficacy of the Sputnik V vaccine, which has been registered in numerous countries worldwide.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Wockhardt
- Press Release Jul 27 2021
- Press Release Jul 22 2021
- Press Release Jul 05 2021
- Press Release May 27 2021
- Press Release Feb 10 2021
Later from Wockhardt
- Press Release Aug 26 2021
- Press Release Nov 08 2021
- Press Release Jan 27 2022
- Press Release Feb 08 2022
- Press Release Mar 16 2022
Follow Wockhardt into a list and get an email when it puts out news.
Follow Wockhardt